SpineGuard SA (EPA:ALSGD)
0.0830
0.00 (0.00%)
Jul 14, 2026, 9:00 AM CET
SpineGuard Market Cap
SpineGuard has a market cap or net worth of €7.79 million as of July 13, 2026. Its market cap has increased by 21.31% in one year.
Market Cap
7.79M
Enterprise Value
7.53M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since April 29, 2013, SpineGuard's market cap has decreased from 31.90M to 7.79M, a decrease of -75.57%. That is a compound annual growth rate of -10.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 7.79M | -13.49% |
| Dec 31, 2025 | 9.01M | -24.10% |
| Dec 31, 2024 | 11.87M | 50.34% |
| Dec 29, 2023 | 7.89M | -57.12% |
| Dec 30, 2022 | 18.41M | -45.36% |
| Dec 31, 2021 | 33.69M | 45.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 207.41M |
| Median Technologies | 176.51M |
| Guerbet | 110.13M |
| Theraclion | 49.86M |
| Mauna Kea Technologies | 32.01M |
| Diagnostic Medical Systems | 30.97M |
| Novacyt | 29.31M |
| Implanet | 24.74M |